Search research articles
Contact Us
Filters
Showing results (61-70 of 245) with videos related to
Page
of 25
Sort By:
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
September 13, 2008
Point-of-care glucose and hemoglobin A1c in emergency department patients without known diabetes: implications for opportunistic screening
Adit A Ginde, Enrico Cagliero, David M Nathan, et al.
Diabetes Care
|
December 22, 2022
Response to Comment on Lachin et al. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial. Diabetes Care 2022;45:2445-2448
John M Lachin, Ionut Bebu, Xiaoyu Gao, et al.
Diabetes Care
|
May 26, 2016
Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications
Ted D Adams, David E Arterburn, David M Nathan, et al.
Diabetes Care
|
August 16, 2022
Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial
John M Lachin, Ionut Bebu, Xiaoyu Gao, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
July 19, 2012
Effect of hospital admission on glycemic control 1 year after discharge
Nancy J Wei, Richard W Grant, David M Nathan, et al.
Annals of Internal Medicine
|
October 1, 2019
To What Target Hemoglobin A1c Level Would You Treat This Patient With Type 2 Diabetes?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Gerald W Smetana, David M Nathan, David C Dugdale, et al.
Annals of Internal Medicine
|
August 21, 2002
Tests of glycemia for the diagnosis of type 2 diabetes mellitus
R Graham Barr, David M Nathan, James B Meigs, et al.
Journal of Diabetes Science and Technology
|
December 7, 2010
Efficacy determinants of subcutaneous microdose glucagon during closed-loop control
Steven J Russell, Firas H El-Khatib, David M Nathan, et al.
Diabetes Care
|
September 28, 2002
Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study
James B Meigs, David M Nathan, Ralph B D'Agostino, et al.
Diabetes Care
|
April 24, 2025
The Diabetes Prevention Program and Its Outcomes Study: NIDDK's Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact
Jill P Crandall, Dana Dabelea, William C Knowler, et al.
Page
of 25
Search research articles
Search
Showing results (61-70 of 245) with videos related to
Sort By:
Page
of 25
Academic Emergency Medicine : Official Journal of the Society for Academic Emergency Medicine
|
September 13, 2008
Point-of-care glucose and hemoglobin A1c in emergency department patients without known diabetes: implications for opportunistic screening
Adit A Ginde, Enrico Cagliero, David M Nathan, et al.
Diabetes Care
|
December 22, 2022
Response to Comment on Lachin et al. Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial. Diabetes Care 2022;45:2445-2448
John M Lachin, Ionut Bebu, Xiaoyu Gao, et al.
Diabetes Care
|
May 26, 2016
Clinical Outcomes of Metabolic Surgery: Microvascular and Macrovascular Complications
Ted D Adams, David E Arterburn, David M Nathan, et al.
Diabetes Care
|
August 16, 2022
Association of Estimated Time-in-Range Capillary Glucose Levels Versus HbA1c With Progression of Microvascular Complications in the Diabetes Control and Complications Trial
John M Lachin, Ionut Bebu, Xiaoyu Gao, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
|
July 19, 2012
Effect of hospital admission on glycemic control 1 year after discharge
Nancy J Wei, Richard W Grant, David M Nathan, et al.
Annals of Internal Medicine
|
October 1, 2019
To What Target Hemoglobin A1c Level Would You Treat This Patient With Type 2 Diabetes?: Grand Rounds Discussion From Beth Israel Deaconess Medical Center
Gerald W Smetana, David M Nathan, David C Dugdale, et al.
Annals of Internal Medicine
|
August 21, 2002
Tests of glycemia for the diagnosis of type 2 diabetes mellitus
R Graham Barr, David M Nathan, James B Meigs, et al.
Journal of Diabetes Science and Technology
|
December 7, 2010
Efficacy determinants of subcutaneous microdose glucagon during closed-loop control
Steven J Russell, Firas H El-Khatib, David M Nathan, et al.
Diabetes Care
|
September 28, 2002
Fasting and postchallenge glycemia and cardiovascular disease risk: the Framingham Offspring Study
James B Meigs, David M Nathan, Ralph B D'Agostino, et al.
Diabetes Care
|
April 24, 2025
The Diabetes Prevention Program and Its Outcomes Study: NIDDK's Journey Into the Prevention of Type 2 Diabetes and Its Public Health Impact
Jill P Crandall, Dana Dabelea, William C Knowler, et al.
Page
of 25